Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi‐factorial randomized controlled trial of low‐ vs. standard‐dose rt‐PA and early intensive vs. guideline‐recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
ConclusionsLow‐dose iv rt‐PA and early intensive BP lowering could provide more affordable and safer use of thrombolysis treatment for patients with AIS worldwide.
Source: International Journal of Stroke - Category: Neurology Authors: Yining Huang, Vijay K. Sharma, Thompson Robinson, Richard I. Lindley, Xiaoying Chen, Jong Sung Kim, Pablo Lavados, Verónica Olavarría, Hisatomi Arima, Sully Fuentes, Huy Thang Nguyen, Tsong‐Hai Lee, Mark W. Parsons, Christopher Levi, Andrew M. Demchuk Tags: Protocol Source Type: research
More News: Clinical Trials | Disability | Health | Health Management | Hemorrhagic Stroke | Hypertension | Internet | Ischemic Stroke | Neurology | Stroke | Study